Search

Search Constraints

You searched for: Author/Creator Pizard, Anne

Search Results

2. Myocardial fibrosis: biomedical research from bench to bedside. (3rd February 2017)

3. Response to: 'Spontaneous hypertensive rat exhibits bone and meniscus phenotypes of osteoarthritis: is it an appropriate control for MetS-associated OA?' by Chan and Wen. Issue 5 (7th October 2017)

4. Potential spironolactone effects on collagen metabolism biomarkers in patients with uncontrolled blood pressure. Issue 4 (18th August 2018)

5. Eplerenone treatment alleviates the development of joint lesions in a new rat model of spontaneous metabolic-associated osteoarthritis. Issue 2 (5th May 2017)

6. The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart 'OMics' in AGEing (HOMAGE) randomized clinical trial. (20th November 2020)

8. Myocardial fibrosis: biomedical research from bench to bedside. (February 2017)

9. Rationale of the FIBROTARGETS study designed to identify novel biomarkers of myocardial fibrosis. (7th October 2017)

10. Effect of eplerenone in patients with heart failure and reduced ejection fraction: potential effect modification by abdominal obesity. Insight from the EMPHASIS‐HF trial. (16th March 2017)